Patients whose tumor samples showed higher PD-L1 expression levels in the tumor cells had a shorter overall survival (OS) than those with lower PD-L1 expression levels (HR = 0.177 [95% CI 0.038–0.825], p = 0.027; Figure 7A). This evidence concerns the gene CD274 and neoplasm.